How can the Whole Genome Sequencing data be useful and applicable in dealing with serious and rare diseases (i.e. cancer, rare and undiagnosed syndromes)?

Embryolab participated with scientific suggestions and workshops at a major conference held in Mumbai, India in November: Fertility Enhancement Management and More FEMM Conference 2017 (Fertility Enhancement Management)

09/12/2017

Embryolab participated in the 3rd Conference on “In Vitro Fertilisαtion”, organized by the Hellenic Association of Assisted Reproduction Physicians and the Pan-Hellenic Association of Clinical Embryologists

28/02/2018

How can the Whole Genome Sequencing data be useful and applicable in dealing with serious and rare diseases (i.e. cancer, rare and undiagnosed syndromes)?

08/02/2018

Glykeria Samolada at Wellcome Genome Campus

How can the Whole Genome Sequencing data be useful and applicable in dealing with serious and rare diseases (i.e. cancer, rare and undiagnosed syndromes)?
The role and training of Genetic Advisors is essential as genetic testing is part of the modern, individualized medicine.
The “Shades of Gray” of the questions to be answered from genome analysis are revealed in the “Genomic Practice for Genetic Counselors 2018” seminar. Geneticists, Genetics Advisors and Clinical Geneticists are discussing the challenges they face as the 100,000 Genomes Analysis Project has been completed. The seminar organized at the Wellcome Genome Campus Cambridge and attended by Mrs. Glykeria Samolada, Biologist B.Sc. and Special Genetics Advisor, M.Sc. Molecular Cytogenetics in Embryolab will be completed today. Let’s wait for the experts’ conclusions!